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ABSTRACT Neurodegenerative disease can originate from the misfolding and aggregation of proteins, such as Amyloid-b,
SOD1, or Huntingtin. Fortunately, all cells possess protein quality control machinery that sequesters misfolded proteins, either
refolding or degrading them, before they can self-associate into proteotoxic oligomers and aggregates. This activity is largely
performed by the stress response chaperones (i.e., Hsp70). However, the expression level of molecular chaperones varies
widely among cell types. To understand the potential consequence of this variation, we studied the process of protein
aggregation in the presence of molecular chaperones using mathematical modeling. We demonstrate that protein aggregation,
in the presence of molecular chaperones, is a bistable process. Bistability in protein aggregation offers an explanation for
threshold transitions to high aggregate concentration, which are observed both in vitro and in vivo. Additionally, we show that
slight variations in chaperone concentration, due to natural ﬂuctuations, have important consequences in a bistable system for
the onset of protein aggregation. Therefore, our results offer a possible theoretical explanation for neuronal vulnerability
observed in vivo and the onset of neurodegenerative phenotypes in neurons lacking an effective heat-shock response.
INTRODUCTION
The proper folding of proteins is among the most fundamen-
tal and essential cellular processes. Given the importance of
protein folding and quality control, all cells possess an
elaborate network of molecular chaperones and other compo-
nents for protein homeostasis that facilitate nascent polypep-
tides through this process (1). Chaperones are essential for
guiding folding and protecting against self-association of
misfolded species into protein oligomers and aggregates.
These aggregates are thought to interfere with the normal
functioning of the cell and promote cell dysfunction and
death (2,3). For neurons, this leads to a variety of neuro-
degenerative diseases including Parkinson’s, Huntington’s,
Alzheimer’s, ALS, Scrapie, and others (4).
The primary stress response chaperone (Hsp70) binds to
motifs rich in hydrophobic residues, thus holding inter-
mediates and guiding folding reactions. Consequently, the
sequestering activity of chaperones serves to prevent misfolding
and aggregation (5). Hsp70 together with its co-chaperones
is also capable of escorting substrates to the proteasome for
degradation (6). This process of chaperones targeting misfolded
substrates either toward the refolding or degradation machin-
ery is called protein triage (7).
Threshold phenomena, where changes in a control param-
eter result in a sharp change in an output, have been observed
in a variety of biological systems including the Cdc2-cyclin
B cell-cycle network, the activation of the JNK cascade, and
the lysis/lysogeny switch in the l-phage (8–12). The non-
linear phenomenon common to these different systems is the
presence of a bistable switch that generates these thresholds.
In a bistable system, two stable steady states (and a third, un-
stable steady state) co-exist for a certain range of system pa-
rameters; through perturbations in the system parameters or
environmental conditions, the system can switch between the
two states, in a threshold-dependent manner.
Observations of protein aggregation or refolding often
reveal a similar sharp transition in the system, when chang-
ing the intrinsic properties of the aggregating species or
the concentration of molecular chaperones. For example, in
Caenorhabditis elegans, the shift between nontoxic and
toxic protein aggregates occurs when expression of a protein
containing a 35-mer polyglutamine repeat was increased to
a 40-mer polyglutamine repeat (13). A threshold response
was also observed for the reactivation of denatured G6PDH
in vitro in the presence of DnaK, where a twofold increase in
DnaK concentration resulted in more than a fourfold increase
in G6PDH reactivation (14). The formation of yeast prion
aggregates also displayed threshold-dependent formation of
aggregate ﬁbrils at different concentrations of Hsp104 (15).
We employed mathematical modeling to study the origin
of threshold behavior in protein misfolding and aggregation
in the presence of molecular chaperones. We demonstrate
that the introduction of molecular chaperones into a model of
protein aggregation creates a threshold in the model through
bistability, and that the range of bistability is a function of
chaperone concentration and the propensity for self-association
of the misfolded protein species. We further use the models
to study the potential of the system for stochastic switching
from low to high concentrations of aggregates in individual
cells. These models focus on the initial formation of soluble
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oligomers of an aggregation-prone protein, which recent
experimental studies have implicated as the toxic precursor
species in neurons (16,17).
MATHEMATICAL MODELS
Models of protein aggregation, disaggregation,
and folding
We considered an in vitro system where the substrate protein concentration
was constant, and there was no chaperone-assisted degradation of misfolded
proteins. Our models incorporated four intrinsic processes of protein damage
and quality control (misfolding, aggregation, disaggregation, and refolding).
We modeled the aggregation process using two different mechanistic de-
scriptions of the process. First, we considered a lumped aggregate model,
where one species described all aggregated proteins; this lumped aggregate
also acted as a catalyst for further aggregation (18,19). Similar models of
protein aggregation, which included explicit autocatalytic formation of the
aggregates, have been used previously to describe the prion aggregation
process (19,20). Second, we separated the growing aggregate into discrete
aggregation states. In this formulation, we included new species for each
additional monomer we allowed to incorporate into the aggregate nucleus.
Common to both aggregate models was the inclusion of disaggregation
and refolding steps, which we assumed were functions of the molecular
chaperone concentration.
The lumped aggregate model
The lumped aggregate model (Fig. 1 A) simpliﬁed the in vitro experiments to
three protein states: a folded state (F), an unfolded protein (U), and the
lumped aggregate (A). Consistent with our model of an in vitro process, we
assumed that the total protein concentration was constant,
½Ptot ¼ ½F1 ½U1 ½A; (1)
where [P]tot is the total protein concentration, [F] is the concentration of
folded/native proteins, [U] is the concentration of unfolded/misfolded pro
teins, and [A] is the concentration of protein aggregates. In the lumped
aggregate model, the aggregates are not true aggregates, and are actually
individual disease-causing proteins. Molecular chaperones were considered
to catalyze the ﬂuxes from the aggregate to unfolded protein and from the
unfolded protein to the folded protein. Therefore, the maximal rates of these
ﬂuxes were assumed to be proportional to the concentration of molecular
chaperones in the system. The parameters and their dimensionless scaling of
the lumped aggregate model are shown in Table 1. To reﬂect the fact that
FIGURE 1 Lumped aggregate model. (A) The model contains three states:
F, folded protein pool;U, unfolded, aggregation-prone intermediate species;
and A, aggregated proteins. The value Vx represents the ﬂux from one state
to the next. For example, Vu is the unfolding ﬂux from state F to state U.
The values Vd (disaggregation ﬂux) and Vf (folding ﬂux) are assumed to be
proportional to the concentration of molecular chaperones in the system. (B)
Steady states of the system by graphical analysis of va and vd (dimensionless
ﬂuxes; see Table 1), and identiﬁcation of parameter regimes that led to
bistability. (I) Maximal rate of vd (vm,d) greater than the maximal rate of va
(vm,a). (II) Same as I, except vm,d , vm,a. Three steady states are present in
case II. (III) Same maximal rates as II, but the afﬁnity of the aggregates for
self-association was increased above the afﬁnity of chaperones for the
aggregates.
FIGURE 2 Bistability in the lumped aggregate model as a function of
molecular chaperone concentration. (A–C) Steady states of states F, U, and
A versus vm,f and vm,d (dimensionless maximal rates). Dashed segments
denote the unstable steady states. All concentrations scaled by total protein
concentration ([P]tot).
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both the disaggregation and refolding were catalyzed by the molecular
chaperones and aggregation was catalyzed by the aggregate, the lumped
aggregate model was assumed to follow Michaelis-Menten kinetics,
df
dt
¼ vf  vu ¼ vm;f u
km;f 1 u
 f ; (2)
da
dt
¼ va  vd ¼ vm;aa u
km;a1 u
 vm;d a
km;d1 a
; (3)
u ¼ 1 f  a; (4)
where lowercase species indicates dimensionless species, all scaled by [P]tot.
The discrete aggregate model
A number of recent theoretical studies considered the protein aggregation
mechanism in detail (21–24). Based on these studies, we included a growing
aggregate nucleus in the model through the discrete addition of unfolded
protein monomers to oligomers (Fig. 3; explanation of each species in Table
2). In contrast to the lumped aggregate model, the molecular chaperones
were treated as individual, dynamic species in the discrete aggregate model.
The total concentration of protein and molecular chaperones were assumed
to be conserved in the discrete aggregate model,
½Ptot ¼ ½F1 ½U1 ½U : HSP1 2ð½A21 ½A2 : HSPÞ
1 3ð½A31 ½A3 : HSPÞ; (5)
½HSPtot ¼ ½HSP1 ½U : HSP1 ½A2 : HSP1 ½A3 : HSP;
(6)
where [P]tot is the total concentration of protein, and [HSP]tot is the total
concentration of molecular chaperones (heat-shock proteins). In addition, we
deﬁned a dimensionless ‘‘total aggregate’’ quantity that reﬂected the per-
centage of total protein in the various aggregate species:
We included oligomers up to a size of three monomer units because the
formation of larger aggregates, more than three monomers, does not change
the qualitative behavior of the system and the minimum size of the system
provides insight on the origins of the observed threshold phenomena.
The formation of the dimer species is distinct because of the association of two
monomers versus the association of a small oligomer and a monomer. In
addition, the inclusion of at least two oligomeric species allowed us to
test explicitly the effect of the two different equilibrium constants (monomer-
monomer versus aggregate-monomer association) on the bistability.
We used generalized mass-action kinetics for the mathematical formu-
lation of the discrete aggregate model (explanation of the kinetic and ther-
modynamic parameters and their dimensionless scaling in Table 3),
u ¼ 1 f  uh 2 3 ða21 a2hÞ  3 3 ða31 a3hÞ; (8)
h ¼ a uh a2h a3h; (9)
df
dt
¼ kf 3 uh1 kruðu Gu 3 f Þ; (10)
da2
dt
¼ kra2ðGa2 3 u2  a2Þ1 krd2ða2h Gd2 3 a2 3 hÞ
1 kra3ða3  Ga3 3 u 3 a2Þ1 kd3 3 a3; (11)
da3
dt
¼ krd3ða3h Gd3 3 a3 3 hÞ1 kra3ðGa3 3 u 3 a2  a3Þ;
(12)
duh
dt
¼ krfðGf 3 u 3 h uhÞ  kf 3 uh1 kd2 3 a2h
1 kd3 3 a3h; (13)
da2h
dt
¼ krd2ðGd2 3 a2 3 h a2hÞ  kd2 3 a2h; (14)
da3h
dt
¼ krd3ðGd3 3 a3 3 h a3hÞ  kd3 3 a3h: (15)
TABLE 1 Mechanistic assumptions and parameters of the lumped aggregate model
Flux* Parameter Interpretation Dimensionless scaling
Vu Flux from F to U (unfolding) vu ¼ Vu3½Ptot
ku
ku Rate constant of protein unfolding Time scaling
Vf Flux from U to F (refolding) vu ¼ Vu3½Ptot
ku
Vm,f Maximal rate of refolding vm;f ¼ Vm;f3½Ptot
ku
Km,f Afﬁnity of chaperones for unfolded substrate km;f ¼ Km;f½Ptot
Va Flux from U to A (aggregation) va ¼ Va
ku
Vm,a Maximal rate of protein aggregation vm;a ¼ Vm;a
ku
Km,a Afﬁnity of misfolded substrates for preformed aggregates km;a ¼ Km;a½Ptot
Vd Flux from A to U (disaggregation) vd ¼ Vd3½Ptot
ku
Vm,d Maximal rate of disaggregation by molecular chaperones vm;d ¼ Vm;d3½Ptot
ku
Km,d Afﬁnity of chaperones for aggregated protein km;d ¼ Km;d½Ptot
t Time t ¼ ku3t
*From Fig. 1 A.
½Atot
½Ptot
¼ 2ð½A21 ½A2 : HSPÞ1 3ð½A31 ½A3 : HSPÞ½F1 ½U1 ½U : HSP1 2ð½A21 ½A2 : HSPÞ1 3ð½A31 ½A3 : HSPÞ: (7)
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RESULTS
Bistability as a function of molecular chaperone
concentration in the lumped aggregate model
The steady-state (time-invariant) behavior of low-dimension
nonlinear systems is often analyzed using graphical analysis
(25,26). The steady-state concentration of aggregates was de-
termined from the condition that the dimensionless aggrega-
tion ﬂux, va, equals the dimensionless disaggregation ﬂux, vd:
va ¼ vd: (16)
Plotting va and vd versus the dimensionless concentration of
aggregate showed that three steady states were possible in
this system (Fig. 1 B, case II). Therefore, the system was cap-
able of displaying bistability. However, two conditions should
be satisﬁed for three steady states to exist; see below.
Condition 1
The maximal dimensionless rate of protein aggregation (vm,a)
must be greater than the maximal dimensionless rate of dis-
aggregation (vm,d). Otherwise, only one steady state will exist
(Fig. 1 B, case I).
Condition 2
The slope of vd must be greater than the slope of va at
[A]¼ 0, or only one or two steady states will be present. This
condition can be satisﬁed through the combination of several
parameters, including decreasing the relative afﬁnities of the
aggregates for self-association versus association with chap-
erones (Fig. 1 B, case III), or increasing the chaperone con-
centration or activity for disaggregation (see Appendix).
With the regime of bistability in the model established, we
tested the effect of variations in the protein quality control
machinery on the appearance of aggregation thresholds.
Conditions 1 and 2 are functions of the maximal rates of
disaggregation and refolding. Therefore, changes in the
molecular chaperone concentration affected the number of
steady states possible in the system. Varying these maximal
rates in the model conﬁrmed that above a critical threshold
in molecular chaperone concentration there was only one
steady state of the network, mostly folded proteins, and no
aggregated protein (Fig. 2, A–C). However, once the
chaperone concentration was lowered below this critical
threshold, a new state emerged, which contained the proteins
in aggregated form. Cells that operate at a chaperone concen-
tration below this bifurcation point can effectively switch
between the two states; in other words, cells with no ag-
gregates could switch to the high aggregation state if an
aggregate seed of sufﬁcient size appeared in the system.
Bistability in a discrete protein aggregate model
We used the deﬁciency theory to determine the existence of
multiple steady states in the mass-action discrete aggregate
model (27,28). The analysis also provided the values of di-
mensionless parameters that gave rise to bistability, which
resulted in physiological ratios for the rates and afﬁnities of
the different biophysical processes (Table 3). For example,
we chose the dimensionless afﬁnity of the chaperones for
their substrates to be signiﬁcantly higher than the dimension-
less afﬁnity of the unfolded proteins for self-association to
reﬂect the use of ATP to drive tight associations of Hsp70
with its substrates (29). Similarly, we chose the dimension-
less rate constant for spontaneous refolding (kru) as several
orders-of-magnitude slower than the dimensionless rate
constant of chaperone-assisted refolding (kf) to reﬂect the
established catalytic role of chaperone protein refolding.
Finally, we used the common assumption of fast reversible
rate constants by choosing the dimensionless reversible rate
constants (krx) to be several orders-of-magnitude greater than
the catalytic rate constants (kx). Interestingly, similar path-
FIGURE 3 Discrete aggregate model. State F represents the folded
proteins; U represents the unfolded protein. The addition of two U
monomers forms A2, the initial aggregate species. The addition of another U
monomer to A2 creates A3. ‘‘X:HSP’’ indicates ‘‘X complexed with HSP’’,
where X is U, A2, or A3. The kinetic and thermodynamic parameters
associated with each step are labeled on the diagram; ki is an irreversible rate
constant for step ‘i’, kri is the reverse or backward step for reversible reaction
‘i,’ and Keqi is the equilibrium constant for a set of reversible reactions ‘i’.
For example, Keqd2 is the equilibrium constant associated with the reversible
binding of HSP to A2 (forming A2:HSP), k
r
d2 is the rate constant for
dissociation of the A2:HSP complex back to A2 and HSP, and kd2 is the rate
constant of the catalytic disaggregation of A2:HSP to U:HSP and U. For
clarity, only the association is shown explicitly for each reversible reaction.
TABLE 2 Species in the discrete aggregate model and their
dimensionless scaling
Species* Interpretation Dimensionless scalingy
F Folded or native proteins f ¼ ½F=½Ptot
U Unfolded proteins u ¼ ½U=½Ptot
A2 Protein dimer a2 ¼ ½A2=½Ptot
A3 Protein trimer (oligomer) a3 ¼ ½A3=½Ptot
HSP Free heat shock protein (HSP) h ¼ ½HSP=½Ptot
U:HSP Unfolded protein bound to an HSP uh ¼ ½U : HSP=½Ptot
A2:HSP Dimer with a bound HSP a2h ¼ ½A2 : HSP=½Ptot
A3:HSP Trimer with a bound HSP a3h ¼ ½A3 : HSP=½Ptot
*From Fig. 3.
y[P]tot ¼ Concentration of total protein (see Eq. 3).
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ways or processes had comparable orders of magnitude for
their rate and equilibrium constants. Also interesting, the two
Conditions of the lumped aggregate model for bistability
also held for the dimensionless parameters of the discrete
aggregate model. This demonstrated the utility of simple
models, such as the lumped aggregate model, for elucidating
the features or design of more complicated biological systems.
Using the parameters in Table 3, we simulated the discrete
aggregate model with varying total molecular chaperone con-
centration. The discrete aggregate model displayed bistability
similar to the lumped aggregatemodel (Fig. 4A). However, this
detailed mechanistic model provided better insight on the re-
sponse of protein aggregation to changes on chaperone activity,
and allowed us to investigate the impact of other physicochem-
ical parameters on the bistable behavior of the system.
For these parameters, the range of the concentration of
molecular chaperones to the concentration of the total protein
where we observed bistability was between a ratio of 0.16
and 0.21. This concentration range was similar to the thresh-
old observed in the disaggregation of amyloidlike structures
of Sup35 by Hsp104, which occurred at a concentration ratio
near 0.07 (15). However, the ratio of molecular chaperones
to total substrate where the threshold transition to low or high
aggregate concentrations occurs is dependent on both the
type of chaperone and the substrate. For example, the in vitro
threshold for reactivation of G6PDH by DnaK occurred
between a ratio of concentrations of 3–6 for DnaK to G6PDH
(14). In general, we would not expect an exact correspondence
between the values of the model parameters and the exper-
imentally observed threshold values because of unaccounted-
for processes in vivo, such as chemical modiﬁcations of
protein substrates, and an unknown relationship between the
concentration of molecular chaperones and their effective
activity for protein quality control.
In the discrete aggregate model, after the initial formation
of the A2 dimer, subsequent aggregation steps were more
thermodynamically favorable, a fact that effectively intro-
duced the feedback activation of aggregate formation found
in the lumped aggregate model. To assess the dependence of
bistability on the relative equilibrium constants between
unfolded protein and dimer/oligomer concentration, we per-
formed a two-parameter bifurcation analysis (Fig. 4 B).
We speciﬁcally investigated the behavior of the system for
the different chaperone concentrations when the initial
aggregate formation was thermodynamically less favorable
Keqa2,K
eq
a3
 
; equally favorable Keqa2 ¼ Keqa3
 
; and more
TABLE 3 Parameters of the discrete aggregate model, their dimensionless scaling, and their dimensionless numerical value
Parameter* Interpretationyz
Dimensionless
parameter Scaling{
Numerical
value
Parameters associated with protein unfolding
kru Rate constant for unassisted refolding of U to F k
r
u k
r
u=k
f
u 1 3 10
1
Kequ Equilibrium between U and F Gu K
eq
u 1 3 10
1
Parameters associated with protein aggregation
kra2 Rate constant for disassociation of A2 to 2U k
r
a2 k
r
a2=k
f
u 1 3 10
3
Keqa2 Equilibrium between A2 and U Ga2 K
eq
a23½Ptot 5 3 100
kra3 Rate constant for disassociation of A3 to A2, U k
r
a3 k
r
a3=k
f
u 1 3 10
3
Keqa3 Equilibrium between A3 and A2, U Ga3 K
eq
a33½Ptot 1 3 101
Parameters associated with protein refolding
krf Rate constant for unfolded protein-HSP association k
r
f k
r
f=k
f
u 1 3 10
3
Keqf Equilibrium between the U:HSP and U, HSP Gf K
eq
f 3½Ptot 1 3 102
kf Rate constant of chaperone assisted refolding kf kf=k
f
u 1 3 10
1
Parameters associated with disaggregation
by molecular chaperones
krd2 Rate constant for dissociation of A2:HSP to A2, HSP k
r
d2 k
r
d2=k
f
u 1 3 10
3
Keqd2 Equilibrium between A2:HSP and A2, HSP Gd2 K
eq
d23½Ptot 1 3 103
kd2 Rate constant for disaggregation of the dimers kd2 kd2=k
f
u 3 3 10
1
krd3 Rate constant for dissociation of A3:HSP to A3, HSP k
r
d3 k
r
d3=k
f
u 1 3 10
3
Keqd3 Equilibrium between A3:HSP and A3, HSP Gd3 K
eq
d33½Ptot 1 3 103
kd3 Rate constant for disaggregation of trimers kd3 kd3=k
f
u 3 3 10
1
Ratio between total chaperones and total protein Concentration ratio between the total chaperones
and total protein
a ½HSPtot=½Ptot Varied
*From Fig. 3.
yAll equilibrium constants are deﬁned as association constants. For example, Keqa2 ¼ ½A2½U2:zForward rate constants were determined by multiplying the equilibrium constant by the reversible rate constant.
{Time is scaled by the forward rate constant of protein unfolding, kfu ¼ kru3Kequ 0t ¼ kfu3 t:
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favorable Keqa2.K
eq
a3
 
than the larger aggregate formation. In
all three regimes, the model displayed bistability. However,
the critical chaperone concentrations depended on the
equilibrium constants of aggregate formation; the bistable
switch occurred at higher chaperone concentrations if the
formation of the ﬁrst, small oligomers was more favorable that
the larger ones (Fig. 4 C). This implied that the formation of
small oligomers was the determining step for initiation of
protein aggregation.
The molecular chaperones are necessary
for bistability
The process of protein aggregation, without molecular chap-
erones, is a competition between the thermodynamic driving
forces for aggregation versus spontaneous refolding. The
driving force of aggregation is proportional to the equilib-
rium constant between the unfolded monomers and the small
oligomers Keqa2
 
; and spontaneous refolding is inversely pro-
portional to the equilibrium constant of unfolding Kequ
 1
:
Therefore, we quantiﬁed the competition between refolding
and protein aggregation by deﬁning a new dimensionless
parameter,
rfold[
driving force for folding
driving force for aggregation
¼ 1=Guð Þ
Ga2
; (17)
which reﬂected how much spontaneous refolding was ther-
modynamically favored versus aggregation. For all values
of rfold, the presence of a bistable transition in the system
was only observed for non-zero values of chaperone
concentration (Fig. 5 A). In fact, using deﬁciency theory
(27,28), we determined that the refolding and disaggregation
activities of the molecular chaperones were necessary for
a bistable threshold to exist in the discrete aggregate model.
Below the bistable regime, the total aggregate concentration
decreased monotonically as the rfold was increased to favor
refolding (Fig. 5 B). However, within the bistable regime, the
appearance of a second stable steady state allowed the sys-
tem to transition from relatively high aggregate concentra-
tion to low aggregate concentration, without any change in
the thermodynamics of refolding and aggregation. These
results suggested that even at low chaperone concentrations
and high aggregation potential, the chaperone quality control
mechanism is capable of preventing aggregation through the
introduction of this bistable threshold.
Intrinsic noise and the onset of aggregation
At the cellular level, low protein concentrations lead to sig-
niﬁcant ﬂuctuations in the distribution of species and devi-
ations from deterministically predicted time courses (30,31).
The intrinsic noise in a bistable intracellular process has the
potential for the ﬂuctuations in the concentration of certain
species to cross a critical threshold and switch between
steady states. Such phenomena occur in several biological
systems such as the Sonic-Hedgehog signaling and the lysis-
lysogeny switch of the bacteriophage-l (12,32,33).
We performed a stochastic simulation of the discrete ag-
gregate model to investigate the effect of intrinsic noise in
protein aggregation. We simulated the stochastic dynamics
of our system using the Gibson algorithm, an efﬁcient
FIGURE 4 Bistability in the discrete aggregate model. (A) Bistability of
folded, unfolded, and aggregated proteins as a function of scaled molecular
chaperone concentration. The steady states of folded (solid line), unfolded
(dashed-dotted line), and total aggregated (dashed line) proteins are shown.
(B) Two-dimensional bifurcation diagram of the bistable region as a function
of Keqa2and scaled HSP concentration. Horizontal lines indicate K
eq
a2 relative to
Keqa3 : K
eq
a2 ,K
eq
a3 (solid line), K
eq
a2 ¼ Keqa3 (dashed line), and Keqa2 .Keqa3(dash-dot
line). (C) Steady-states of state-scaled aggregated protein versus scaled HSP
concentration with the three ratios of Keqa2 /K
eq
a3 from B. (Solid line) K
eq
a2 ,K
eq
a3 ;
(dashed line) Keqa2 ¼ Keqa3 ; and (dash-dotted line) Keqa2 .Keqa3 : Thin-line seg-
ments denote the unstable steady state.
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modiﬁcation of the Gillespie algorithm (34–36), and we
studied the effect of intrinsic noise on the formation of ag-
gregates within the low-chaperone concentrations, high-
aggregate regime (Fig. 6 A). The deterministic response
reached 50% of its maximal value at time¼ 9.5 (all times are
dimensionless); however, only 63% of the cells had reached
their 50% maximal value at this time (Fig. 6 B). The most
rapid aggregating cells achieved 50% maximal aggregation
in approximately half the time of the deterministic simulation
(time 5), and the slowest aggregating cells did not reach
their 50% maximal value until time 25. Additionally, the
wide distribution of transition times from low to high aggre-
gated states led to a distribution of aggregation states (Fig. 6
C); in other words, the initially homogeneous population
underwent a transition through which the population was dis-
tributed between a low and high protein aggregate concen-
tration.
Comparison of the transient dynamics to in vitro experi-
ments showed that the timescale of this transient was 1–2 h
(14,15). Thus, a perturbation to the protein quality control
machinery that results in the system crossing the bifurcation
point to high aggregate concentration will lead to rapid
formation of protein aggregates. However, additional time-
scales inﬂuence the time of onset for protein aggregates in
vivo. These processes include the time for expression and ac-
cumulation of disease-causing proteins, and the slow time for
changes to occur in the activity or concentration of the protein
quality control machinery.
DISCUSSION
We presented a theoretical analysis of the process of protein
aggregation and rescue by molecular chaperones. Our model
FIGURE 6 Stochastic simulations of the discrete aggregatemodel ([HSP]tot/
[P]tot ¼ 0.16). (A) Plotted is a representative sample (33) of the stochastic
dynamics of 482 stochastic simulations (solid lines); the equivalent de-
terministic result is also included (thick dashed line). Time is dimensionless,
scaled by the rate constant of unfolding (kfu). (B) Time of crossing to high
aggregate concentration. The time [A]tot/[P]tot ¼ 0.50 for each cell is
summarized in the histogram. The deterministic time is included for reference
(dashed line). (C) The scaled aggregate concentration in each cell at time¼ 9.5.
The deterministic value is included for reference (dashed line).
FIGURE 5 Competition between refolding and aggregation versus HSP
concentration. (A) Two-parameter continuation of rfold versus [HSP]tot/[P]tot.
(B) [A]tot/[P]tot versusrfold for three different chaperone concentrations ([HSP]tot/
[P]tot¼ 0.001 (dashed line), 0.005 (dash-dotted line), and 0.01 (solid line)). Thin
line segments denote the unstable steady state.
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displayed a threshold for the formation of protein aggregates
with respect to both intrinsic properties of the protein (equi-
librium constants for self-association) and extrinsic proper-
ties of the system (concentration of molecular chaperones).
Previous experimental studies showed that a threshold exists
for the formation of protein aggregates with respect to both
of these properties. In vitro studies showed thresholds with
respect to the concentration of molecular chaperones for
several different substrates and chaperones (14,15). Addi-
tionally, the expression of different length polyglutamine
expansions in C. elegans showed a polyQ-dependent in-
crease in the number of observed aggregates, and a dramatic
decrease in the time of aggregation onset between a polyglu-
tamine expansion of Q35 and Q40 (13). In vivo aggregation
processes are far more complicated than the reactions in the
model. For example, the model does not contain any explicit
information about chemical modiﬁcations of polyQ proteins
post-aggregation. However, the model does implicitly
capture the effect of expanding the polyglutamine repeat,
which in the model is equivalent to increasing the propensity
of the proteins for self-association. Based on the analysis of
our models, we proposed that a nonlinear phenomena known
as bistability caused the threshold. The presence of bistability
in the system has signiﬁcant implications for the onset and
potential prevention of protein aggregation. Potential therapies
must account for hysteresis in bistable systems. For example,
reduction of the concentration of molecular chaperones drives
the system to the upper aggregate state. Restoration of the
system to the low aggregate steady state requires an increase
of the concentration of the molecular chaperones above the
level at which bistability exists to overcome the hysteresis
phenomena due to bistability.
The essential nature of the molecular chaperones machin-
ery for generating the bistable switch revealed an interesting
interplay between protein aggregation and molecular chap-
erone production and potential consequences for the failure
of the heat-shock response. Our analysis showed that the
molecular chaperones maintained the system in the low ag-
gregate steady state, even as conditions increasingly favored
the formation of protein aggregates. However, one of the
unique aspects of many neuronal cell types is their inability
to induce Hsp70 expression above basal levels under stress
(37,38). Therefore, cellular stresses coupled with slow deg-
radation of chaperones activity or concentration could cause
the system to cross the threshold from the bistable region to
the high-aggregate steady state.
In vivo, each individual biophysical process of the model
is more complicated than simple self-association or chaper-
one binding; mechanistically, each process might require the
binding of cofactors, hydrolysis of ATP, etc. However, the
use of different models and the parametric analyses showed
that the basic observation of bistability is robust to several
mechanistic assumptions and parameter values. The ﬁnding
that a simple mechanism generates the expected threshold is
signiﬁcant because there are many in vivo mechanisms for
irreversible protein aggregation. For example, for the
particular case of polyQ-associated disorders, the aggregates
are cross-linked by transglutaminase (39). This process of
cross-linking generates irreversible aggregates. Although
this cross-linking contributes to the long-time formation of
Huntingtin aggregates, the model demonstrates that this
modiﬁcation and other possible biochemical modiﬁcations
of the protein aggregates are not necessary for the system to
display a switch to high levels of protein aggregates. The
origin of the bistable switch is in the feedback from the
cellular protein quality control machinery, and its interac-
tions (or failure to interact) with the misfolded substrates.
It is important to distinguish between the steady state of
the protein aggregates and the timescale for the appearance
and formation of protein aggregates. Steady-state analysis
indicates whether aggregates will form, given certain intrinsic
and extrinsic properties of the system. Many of these prop-
erties inﬂuence the timescale or dynamics for the appearance
and formation of aggregates. The activity of the molecular
chaperones is an extrinsic property of the system that may drift
(become impaired) over years or decades, and this drift in
activity may cause the system to cross the steady-state thresh-
old to the high aggregate steady state and induce the formation
of protein aggregates. In addition, we showed that intrinsic
stochastic ﬂuctuations inﬂuenced the timescale for formation
of protein aggregates. These ﬂuctuations led to the ensembles
forming aggregates over a broad distribution of times. Thus,
individuals with the same genotype can form aggregates at
very different ages. However, the current state of the model
does not address at what point protein aggregates become
toxic to neurons and lead to the onset of neurodegenerative
disorders, since, like most of the diseases, this depends on the
function of many other cellular processes.
A whole genome RNAi screen in C. elegans identiﬁed 186
genes whose protein products act as modiﬁers of protein
aggregation (40). This revealed that the prevention of protein
aggregation is not the sole responsibility of the chaperone
machinery, but involves the complex interaction of many
essential intracellular processes. For example, of the 186 genes,
14 genes were associated with protein degradation pathways
and the proteasome. Chaperones enhance the in vivo rate of
dissociation and degradation of aggregates. Because enhanced
clearance of aggregates also requires the degradative machin-
ery, we can suggest that it is both the chaperone folding
machinery and the degradative/clearance machinery of protea-
somes, and that autophagy must be involved. Although
chaperones are an essential component of these events, they
are not the only components necessary for the proper
dissociation of damaged proteins in the cell. Therefore, a full
description of the in vivo process and identiﬁcation of potential
points of failure of protein homeostasis will require a more
detailed description of this process and its interaction with the
molecular chaperone machinery and protein aggregates (41).
Mathematical models allow us to consider each essential piece
of the complex biology individually and to begin to incorporate
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these components into a more complete theory for the design
of protein quality control in the human cell.
APPENDIX: CONDITION 2 IN THE LUMPED
AGGREGATE MODEL
Condition 2 required that the slope of vd was greater than the slope of va near
a ¼ 0:
@vd
@a

a/0
.
@va
@a

a/0
; (18)
where
vd ¼ vm;d a
km;d1 a
(19)
va ¼ vm;aa u
km;a1 u
: (20)
Taking the derivative of vd and va with respect to a:
@vd
@a
¼ vm;d km;dðkm;d1 aÞ2
/
a¼0 vm;d
km;d
(21)
@va
@a
¼ vm;a u
km;a1 u
1 a
km;a
ðkm;a1 uÞ2
@u
@a
  
: (22)
The second term in Eq. 22 was neglected since a ¼ 0. However, to evaluate
the ﬁrst term, we solved for u as a function of a. We solved for u as a function
of a using the conservation of total protein (Eq. 4) and the steady-state
expression for f:
f ¼ vm;f u
km;f 1 u
; (23)
which resulted in a quadratic expression for f as a function of a:
f ¼ 1 a1b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d1 a 3 l
p
2
; (24)
where b ¼ vm,f1 km,f, d ¼ 11 2(km,f  vm,f), and l¼ a  2(km,f  vm,f1
1). Combining Eq. 24 with Eq. 4,
u ¼ 1 a b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d1 a 3 l
p
2
: (25)
The resulting expression for Eq. 22, at a ¼ 0:
@va
@a

a¼0
¼ vm;a 1 b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d
p
2km;a1 1 b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d
p
" #
: (26)
Therefore, the full Condition 2:
vm;d
km;d
. vm;a
1 b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d
p
2km;a1 1 b6
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
b
21 d
p
" #
: (27)
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